Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers

NYU Langone Medical Center, New York

University of Pennsylvania, Philadelphia

Thomas Jefferson University, Philadelphia

Maryland Oncology Hematology, Rockville

Virginia Cancer Specialists, Fairfax

Clínica Universidad de Navarra -Madrid, Madrid

Hospital Universitario La Paz, Madrid

Hospital Universitario HM Sanchinarro - CIOCC, Madrid

Levine Cancer Institute, Charlotte

Prisma Health, Greenville

Augusta Oncology, Augusta

Miami Cancer Institue, Baptist Health South Florida, Miami

University of South Florida, Tampa

Sarah Cannon Research Institute, Nashville

Ohio State University, James Cancer Center, Columbus

University of Cincinnati Cancer Institute, Cincinnati

Medical College of Wisconsin, Milwaukee

Minnesota Oncology Hematology, Minneapolis

University of Chicago, Chicago

Rocky Mountain Cancer Center, Aurora

Arizona Oncology - Tucson, Tucson

Comprehensive Cancer Centers of Nevada, Las Vegas

UCLA Jonsson Comprehensive Cancer Center Clinical Research Unit, Los Angeles

Sutter Health- Palo Alto Medical Foundation, San Francisco

Cancer Care Northwest-South Spokane, Spokane

Yale School of Medicine, New Haven

Vall d'Hebron Institut d'Oncologia, Barcelona